{"id":7228,"date":"2021-12-22T06:16:01","date_gmt":"2021-12-21T21:16:01","guid":{"rendered":"https:\/\/www.emukk.com\/WP\/?p=7228"},"modified":"2021-12-22T06:20:01","modified_gmt":"2021-12-21T21:20:01","slug":"interleukin-6-to-lymphocyte-il-6-lym-ratio-has-high-power-to-predict-negative-outcome-in-patients-with-sars-cov-2-infection","status":"publish","type":"post","link":"https:\/\/www.emukk.com\/WP\/en\/interleukin-6-to-lymphocyte-il-6-lym-ratio-has-high-power-to-predict-negative-outcome-in-patients-with-sars-cov-2-infection\/","title":{"rendered":"Interleukin-6 to lymphocyte (IL-6\/Lym) ratio has high power to predict negative outcome in patients with SARS-CoV-2 infection"},"content":{"rendered":"

A group from internal Medicine II, San Giuseppe Hospital, Empoli, Italy, etc. has reported that Interleukin-6 to lymphocyte (IL-6\/Lym) ratio has high power to predict negative outcome in patients with respiratory failure associated with SARS-CoV-2 infection
\nhttps:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8660176\/<\/a><\/p>\n

AUC (0.797, 95% CI: 0.738\u20130.848) of IL-6\/Lym ratio in SARS-CoV-2 related pneumonia was the highest compared with those of all the other analyzed biomarkers and the difference was significant with the exception of IL-6.<\/p>\n

Despite the exact pathophysiology mechanism in Acute Respiratory Distress Syndrome (ARDS) of COVID-19 remains unclear, much studies shows that high levels of IL-6 and low lymphocytes count are biomarkers of cytokine storm and immune response in COVID-19. However the predictive power of these biomarkers is evaluated singularly. Combining two biomarkers by using the ratio between them could increase their predictive power. <\/p>\n

In COVID-19 patients lymphocytes count has been included in a lot of ratios with other biomarkers for testing outcomes such as neutrophil\/lymphocyte (Neu\/Lym) ratio, platelets\/Lym ratio, Lym\/CRP ratio, lymphocyte to monocyte ratio, eosinophil to lymphocyte ratio . On the other hand, recently IL-6\/Lym ratio has been proposed as an interesting prognosticator in patients with COVID-19. <\/p>\n","protected":false},"excerpt":{"rendered":"

A group from internal Medicine II, San Giuseppe Hospital, Empoli, Italy, etc. has reported that Interleukin-6 <\/p><\/div>\n

\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[70,7],"tags":[],"class_list":["post-7228","post","type-post","status-publish","format-standard","hentry","category-nature-en","category-technology-en"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t